About: Cubist Pharmaceuticals

Property	Value
dbo:abstract	Cubist Pharmaceuticals was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, MA. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash ($8.4 billion). (en)
dbo:foundingYear	1992-01-01 (xsd:gYear)
dbo:industry	dbr:Pharmaceuticals
dbo:location	dbr:Lexington,_Massachusetts
dbo:parentCompany	dbr:Merck_&_Co.
dbo:product	http://www.cubist.com/products/
dbo:revenue	9.264E8 (dbd:usDollar)
dbo:thumbnail	wiki-commons:Special:FilePath/Cubist_Pharmaceuticals_Logo.svg?width=300
dbo:type	dbr:Public
dbo:wikiPageExternalLink	http://www.cubist.com/ http://www.cubist.com/products/
dbo:wikiPageID	31836335 (xsd:integer)
dbo:wikiPageLength	7538 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1122471321 (xsd:integer)
dbo:wikiPageWikiLink	dbc:1992_establishments_in_Massachusetts dbr:Public dbr:Methicillin-resistant_Staphylococcus_aureus dbr:Paul_Schimmel dbc:Biotechnology_companies_disestablished_in_2015 dbr:United_States_dollar dbc:2015_mergers_and_acquisitions dbc:Biotechnology_companies_of_the_United_States dbc:Pharmaceutical_companies_established_in_1992 dbr:Constipation dbr:Lexington,_Massachusetts dbr:Michael_Bonney dbc:Pharmaceutical_companies_disestablished_in_2015 dbc:2015_disestablishments_in_Massachusetts dbc:American_companies_established_in_1992 dbc:Defunct_companies_based_in_Massachusetts dbr:Daptomycin dbr:Food_and_Drug_Administration dbc:Companies_formerly_listed_on_the_Nasdaq dbr:Tedizolid dbc:Biopharmaceutical_companies dbc:Companies_based_in_Lexington,_Massachusetts dbc:Defunct_pharmaceutical_companies_of_the_United_States dbc:Health_care_companies_based_in_Massachusetts dbc:Life_sciences_industry dbc:Merck_&_Co. dbc:Biotechnology_companies_established_in_1992 dbr:Biopharmaceutical dbr:Merck_&_Co. dbr:Optimer_Pharmaceuticals dbr:Trius_Therapeutics dbr:Lipopeptides dbr:Teva_Pharmaceutical_Industries dbr:Pharmaceuticals
dbp:defunct	2015 (xsd:integer)
dbp:foundation	1992 (xsd:integer)
dbp:homepage	http://www.cubist.com/
dbp:industry	dbr:Pharmaceuticals
dbp:keyPeople	Robert J. Perez, President, CEO; (en)
dbp:location	dbr:Lexington,_Massachusetts
dbp:logo	Cubist Pharmaceuticals Logo.svg (en)
dbp:logoSize	228 (xsd:integer)
dbp:name	Cubist Pharmaceuticals, INC (en)
dbp:parent	dbr:Merck_&_Co.
dbp:products	http://www.cubist.com/products/
dbp:revenue	$926.4 million USD (en)
dbp:tradedAs	NASDAQ:CBST (en)
dbp:type	Subsidiary (en)
dbp:wikiPageUsesTemplate	dbt:Authority_control dbt:Coord dbt:Infobox_company dbt:Reflist dbt:Short_description dbt:Profit dbt:Merck_&_Co. dbt:Pharmaceutical_companies_of_the_United_States
dct:subject	dbc:1992_establishments_in_Massachusetts dbc:Biotechnology_companies_disestablished_in_2015 dbc:2015_mergers_and_acquisitions dbc:Biotechnology_companies_of_the_United_States dbc:Pharmaceutical_companies_established_in_1992 dbc:Pharmaceutical_companies_disestablished_in_2015 dbc:2015_disestablishments_in_Massachusetts dbc:American_companies_established_in_1992 dbc:Defunct_companies_based_in_Massachusetts dbc:Companies_formerly_listed_on_the_Nasdaq dbc:Biopharmaceutical_companies dbc:Companies_based_in_Lexington,_Massachusetts dbc:Defunct_pharmaceutical_companies_of_the_United_States dbc:Health_care_companies_based_in_Massachusetts dbc:Life_sciences_industry dbc:Merck_&_Co. dbc:Biotechnology_companies_established_in_1992
gold:hypernym	dbr:S
georss:point	42.42366666666667 -71.24247222222222
rdf:type	owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatBiotechnologyCompaniesOfTheUnitedStates yago:WikicatCompaniesEstablishedIn1992 yago:WikicatCompaniesInTheNASDAQBiotechnologyIndex yago:WikicatCompaniesListedOnNASDAQ geo:SpatialThing yago:Abstraction100002137 yago:Company108058098 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920
rdfs:comment	Cubist Pharmaceuticals was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, MA. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash ($8.4 billion). (en)
rdfs:label	Cubist Pharmaceuticals (en)
owl:sameAs	freebase:Cubist Pharmaceuticals yago-res:Cubist Pharmaceuticals wikidata:Cubist Pharmaceuticals https://global.dbpedia.org/id/4ia2f
geo:geometry	POINT(-71.242469787598 42.423667907715)
geo:lat	42.423668 (xsd:float)
geo:long	-71.242470 (xsd:float)
skos:closeMatch	http://www.grid.ac/institutes/grid.417686.a
prov:wasDerivedFrom	wikipedia-en:Cubist_Pharmaceuticals?oldid=1122471321&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Cubist_Pharmaceuticals_Logo.svg
foaf:homepage	http://www.cubist.com/
foaf:isPrimaryTopicOf	wikipedia-en:Cubist_Pharmaceuticals
foaf:name	Cubist Pharmaceuticals, INC (en)
is dbo:board of	dbr:Michael_Bonney
is dbo:employer of	dbr:Michael_Bonney
is dbo:occupation of	dbr:Michael_Bonney
is dbo:wikiPageRedirects of	dbr:Adolor_Corporation dbr:Cubist_Pharmaceuticals,_Inc.
is dbo:wikiPageWikiLink of	dbr:Bates_College dbr:Bevenopran dbr:List_of_pharmaceutical_companies dbr:Michael_Bonney dbr:Cefluprenam dbr:List_of_Bates_College_people dbr:Alnylam_Pharmaceuticals dbr:Curtis_Wright_IV dbr:Karen_Joy_Shaw dbr:Tedizolid dbr:Surotomycin dbr:Merck_&_Co. dbr:Optimer_Pharmaceuticals dbr:Susan_A._Martinis dbr:Trius_Therapeutics dbr:Adolor_Corporation dbr:Cubist_Pharmaceuticals,_Inc.
is foaf:primaryTopic of	wikipedia-en:Cubist_Pharmaceuticals